nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP2A6—Prednisolone—ankylosing spondylitis	0.147	0.185	CbGbCtD
Norfloxacin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.089	0.112	CbGbCtD
Norfloxacin—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0867	0.109	CbGbCtD
Norfloxacin—CYP1A1—Dexamethasone—ankylosing spondylitis	0.074	0.0929	CbGbCtD
Norfloxacin—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0592	0.0744	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0592	0.0744	CbGbCtD
Norfloxacin—SLC22A6—Methotrexate—ankylosing spondylitis	0.0522	0.0655	CbGbCtD
Norfloxacin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0458	0.0575	CbGbCtD
Norfloxacin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0444	0.0558	CbGbCtD
Norfloxacin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0347	0.0436	CbGbCtD
Norfloxacin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0298	0.0374	CbGbCtD
Norfloxacin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0294	0.0369	CbGbCtD
Norfloxacin—CYP3A4—Prednisone—ankylosing spondylitis	0.0278	0.0348	CbGbCtD
Norfloxacin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0173	0.0218	CbGbCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisone—ankylosing spondylitis	0.000956	0.506	CbGdCrCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.000933	0.494	CbGdCrCtD
Norfloxacin—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000514	0.00255	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000514	0.00255	CcSEcCtD
Norfloxacin—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000514	0.00255	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000514	0.00255	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000511	0.00254	CcSEcCtD
Norfloxacin—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000509	0.00253	CcSEcCtD
Norfloxacin—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000509	0.00253	CcSEcCtD
Norfloxacin—Pancreatitis—Prednisone—ankylosing spondylitis	0.000502	0.00249	CcSEcCtD
Norfloxacin—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000498	0.00247	CcSEcCtD
Norfloxacin—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000495	0.00246	CcSEcCtD
Norfloxacin—Erythema—Prednisolone—ankylosing spondylitis	0.000491	0.00243	CcSEcCtD
Norfloxacin—Neutropenia—Prednisone—ankylosing spondylitis	0.000478	0.00237	CcSEcCtD
Norfloxacin—Irritability—Methotrexate—ankylosing spondylitis	0.000472	0.00234	CcSEcCtD
Norfloxacin—Hallucination—Dexamethasone—ankylosing spondylitis	0.000468	0.00232	CcSEcCtD
Norfloxacin—Hallucination—Betamethasone—ankylosing spondylitis	0.000468	0.00232	CcSEcCtD
Norfloxacin—Ataxia—Methotrexate—ankylosing spondylitis	0.000465	0.00231	CcSEcCtD
Norfloxacin—Vision blurred—Prednisolone—ankylosing spondylitis	0.000462	0.00229	CcSEcCtD
Norfloxacin—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000457	0.00227	CcSEcCtD
Norfloxacin—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000453	0.00225	CcSEcCtD
Norfloxacin—Visual impairment—Betamethasone—ankylosing spondylitis	0.000453	0.00225	CcSEcCtD
Norfloxacin—Erythema—Triamcinolone—ankylosing spondylitis	0.000451	0.00224	CcSEcCtD
Norfloxacin—Erythema—Methylprednisolone—ankylosing spondylitis	0.00045	0.00223	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00045	0.00223	CcSEcCtD
Norfloxacin—Angioedema—Prednisolone—ankylosing spondylitis	0.000448	0.00222	CcSEcCtD
Norfloxacin—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000447	0.00222	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000447	0.00222	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000446	0.00221	CcSEcCtD
Norfloxacin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000442	0.00219	CcSEcCtD
Norfloxacin—Vertigo—Prednisolone—ankylosing spondylitis	0.000441	0.00219	CcSEcCtD
Norfloxacin—Back pain—Triamcinolone—ankylosing spondylitis	0.000436	0.00217	CcSEcCtD
Norfloxacin—Convulsion—Prednisolone—ankylosing spondylitis	0.000425	0.00211	CcSEcCtD
Norfloxacin—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000423	0.0021	CcSEcCtD
Norfloxacin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000419	0.00208	CcSEcCtD
Norfloxacin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000412	0.00205	CcSEcCtD
Norfloxacin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000411	0.00204	CcSEcCtD
Norfloxacin—Erythema—Dexamethasone—ankylosing spondylitis	0.000409	0.00203	CcSEcCtD
Norfloxacin—Erythema—Betamethasone—ankylosing spondylitis	0.000409	0.00203	CcSEcCtD
Norfloxacin—Hallucination—Prednisone—ankylosing spondylitis	0.000408	0.00202	CcSEcCtD
Norfloxacin—Vertigo—Triamcinolone—ankylosing spondylitis	0.000405	0.00201	CcSEcCtD
Norfloxacin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000404	0.00201	CcSEcCtD
Norfloxacin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.0004	0.00199	CcSEcCtD
Norfloxacin—Oedema—Prednisolone—ankylosing spondylitis	0.0004	0.00199	CcSEcCtD
Norfloxacin—Neutropenia—Methotrexate—ankylosing spondylitis	0.0004	0.00198	CcSEcCtD
Norfloxacin—Convulsion—Triamcinolone—ankylosing spondylitis	0.000391	0.00194	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00039	0.00194	CcSEcCtD
Norfloxacin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00039	0.00194	CcSEcCtD
Norfloxacin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000387	0.00192	CcSEcCtD
Norfloxacin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000384	0.00191	CcSEcCtD
Norfloxacin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000383	0.0019	CcSEcCtD
Norfloxacin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000383	0.0019	CcSEcCtD
Norfloxacin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000382	0.0019	CcSEcCtD
Norfloxacin—Drowsiness—Methotrexate—ankylosing spondylitis	0.000381	0.00189	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000378	0.00188	CcSEcCtD
Norfloxacin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000376	0.00186	CcSEcCtD
Norfloxacin—Renal failure—Methotrexate—ankylosing spondylitis	0.000375	0.00186	CcSEcCtD
Norfloxacin—Angioedema—Betamethasone—ankylosing spondylitis	0.000374	0.00186	CcSEcCtD
Norfloxacin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000374	0.00186	CcSEcCtD
Norfloxacin—Stomatitis—Methotrexate—ankylosing spondylitis	0.000372	0.00184	CcSEcCtD
Norfloxacin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000371	0.00184	CcSEcCtD
Norfloxacin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00037	0.00184	CcSEcCtD
Norfloxacin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000368	0.00183	CcSEcCtD
Norfloxacin—Oedema—Triamcinolone—ankylosing spondylitis	0.000368	0.00183	CcSEcCtD
Norfloxacin—Vertigo—Betamethasone—ankylosing spondylitis	0.000368	0.00183	CcSEcCtD
Norfloxacin—Vertigo—Dexamethasone—ankylosing spondylitis	0.000368	0.00183	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000367	0.00182	CcSEcCtD
Norfloxacin—Haematuria—Methotrexate—ankylosing spondylitis	0.000364	0.0018	CcSEcCtD
Norfloxacin—Insomnia—Prednisolone—ankylosing spondylitis	0.000362	0.0018	CcSEcCtD
Norfloxacin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00036	0.00178	CcSEcCtD
Norfloxacin—Erythema—Prednisone—ankylosing spondylitis	0.000357	0.00177	CcSEcCtD
Norfloxacin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000356	0.00177	CcSEcCtD
Norfloxacin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000356	0.00177	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000355	0.00176	CcSEcCtD
Norfloxacin—Convulsion—Betamethasone—ankylosing spondylitis	0.000355	0.00176	CcSEcCtD
Norfloxacin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000355	0.00176	CcSEcCtD
Norfloxacin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000349	0.00173	CcSEcCtD
Norfloxacin—Myalgia—Betamethasone—ankylosing spondylitis	0.000349	0.00173	CcSEcCtD
Norfloxacin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000347	0.00172	CcSEcCtD
Norfloxacin—Anxiety—Betamethasone—ankylosing spondylitis	0.000347	0.00172	CcSEcCtD
Norfloxacin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000342	0.0017	CcSEcCtD
Norfloxacin—Vision blurred—Prednisone—ankylosing spondylitis	0.000336	0.00167	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000336	0.00166	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000335	0.00166	CcSEcCtD
Norfloxacin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000334	0.00166	CcSEcCtD
Norfloxacin—Oedema—Betamethasone—ankylosing spondylitis	0.000334	0.00166	CcSEcCtD
Norfloxacin—Oedema—Dexamethasone—ankylosing spondylitis	0.000334	0.00166	CcSEcCtD
Norfloxacin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000334	0.00166	CcSEcCtD
Norfloxacin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000333	0.00165	CcSEcCtD
Norfloxacin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000332	0.00165	CcSEcCtD
Norfloxacin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000331	0.00164	CcSEcCtD
Norfloxacin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00033	0.00164	CcSEcCtD
Norfloxacin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00033	0.00164	CcSEcCtD
Norfloxacin—Visual impairment—Methotrexate—ankylosing spondylitis	0.00033	0.00164	CcSEcCtD
Norfloxacin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000328	0.00163	CcSEcCtD
Norfloxacin—Agitation—Prednisone—ankylosing spondylitis	0.000328	0.00163	CcSEcCtD
Norfloxacin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000327	0.00162	CcSEcCtD
Norfloxacin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000327	0.00162	CcSEcCtD
Norfloxacin—Angioedema—Prednisone—ankylosing spondylitis	0.000326	0.00162	CcSEcCtD
Norfloxacin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000324	0.00161	CcSEcCtD
Norfloxacin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000324	0.00161	CcSEcCtD
Norfloxacin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000323	0.0016	CcSEcCtD
Norfloxacin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000323	0.0016	CcSEcCtD
Norfloxacin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000323	0.0016	CcSEcCtD
Norfloxacin—Vertigo—Prednisone—ankylosing spondylitis	0.00032	0.00159	CcSEcCtD
Norfloxacin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000319	0.00158	CcSEcCtD
Norfloxacin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000319	0.00158	CcSEcCtD
Norfloxacin—Anorexia—Betamethasone—ankylosing spondylitis	0.000319	0.00158	CcSEcCtD
Norfloxacin—Urticaria—Prednisolone—ankylosing spondylitis	0.000318	0.00158	CcSEcCtD
Norfloxacin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000317	0.00158	CcSEcCtD
Norfloxacin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000317	0.00157	CcSEcCtD
Norfloxacin—Convulsion—Prednisone—ankylosing spondylitis	0.000309	0.00153	CcSEcCtD
Norfloxacin—Chills—Methotrexate—ankylosing spondylitis	0.000307	0.00152	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000304	0.00151	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000304	0.00151	CcSEcCtD
Norfloxacin—Arthralgia—Prednisone—ankylosing spondylitis	0.000304	0.00151	CcSEcCtD
Norfloxacin—Myalgia—Prednisone—ankylosing spondylitis	0.000304	0.00151	CcSEcCtD
Norfloxacin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000303	0.00151	CcSEcCtD
Norfloxacin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000303	0.0015	CcSEcCtD
Norfloxacin—Anxiety—Prednisone—ankylosing spondylitis	0.000303	0.0015	CcSEcCtD
Norfloxacin—Insomnia—Betamethasone—ankylosing spondylitis	0.000302	0.0015	CcSEcCtD
Norfloxacin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000302	0.0015	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0003	0.00149	CcSEcCtD
Norfloxacin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0003	0.00149	CcSEcCtD
Norfloxacin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0003	0.00149	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—ankylosing spondylitis	0.000298	0.00148	CcSEcCtD
Norfloxacin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000295	0.00146	CcSEcCtD
Norfloxacin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000294	0.00146	CcSEcCtD
Norfloxacin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000294	0.00146	CcSEcCtD
Norfloxacin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000293	0.00145	CcSEcCtD
Norfloxacin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000292	0.00145	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000292	0.00145	CcSEcCtD
Norfloxacin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000291	0.00144	CcSEcCtD
Norfloxacin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000291	0.00144	CcSEcCtD
Norfloxacin—Oedema—Prednisone—ankylosing spondylitis	0.000291	0.00144	CcSEcCtD
Norfloxacin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00029	0.00144	CcSEcCtD
Norfloxacin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00029	0.00144	CcSEcCtD
Norfloxacin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00029	0.00144	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—ankylosing spondylitis	0.000288	0.00143	CcSEcCtD
Norfloxacin—Fatigue—Betamethasone—ankylosing spondylitis	0.000288	0.00143	CcSEcCtD
Norfloxacin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000288	0.00143	CcSEcCtD
Norfloxacin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000281	0.0014	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000281	0.00139	CcSEcCtD
Norfloxacin—Anorexia—Prednisone—ankylosing spondylitis	0.000277	0.00138	CcSEcCtD
Norfloxacin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000275	0.00137	CcSEcCtD
Norfloxacin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000275	0.00137	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000273	0.00136	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000273	0.00136	CcSEcCtD
Norfloxacin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000271	0.00135	CcSEcCtD
Norfloxacin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000271	0.00134	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—ankylosing spondylitis	0.000268	0.00133	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000267	0.00132	CcSEcCtD
Norfloxacin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000265	0.00132	CcSEcCtD
Norfloxacin—Urticaria—Betamethasone—ankylosing spondylitis	0.000265	0.00132	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000265	0.00132	CcSEcCtD
Norfloxacin—Dizziness—Prednisolone—ankylosing spondylitis	0.000265	0.00131	CcSEcCtD
Norfloxacin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000264	0.00131	CcSEcCtD
Norfloxacin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000264	0.00131	CcSEcCtD
Norfloxacin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000264	0.00131	CcSEcCtD
Norfloxacin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000264	0.00131	CcSEcCtD
Norfloxacin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000264	0.00131	CcSEcCtD
Norfloxacin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000264	0.00131	CcSEcCtD
Norfloxacin—Insomnia—Prednisone—ankylosing spondylitis	0.000263	0.00131	CcSEcCtD
Norfloxacin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000261	0.0013	CcSEcCtD
Norfloxacin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000261	0.00129	CcSEcCtD
Norfloxacin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00026	0.00129	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—ankylosing spondylitis	0.000258	0.00128	CcSEcCtD
Norfloxacin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000256	0.00127	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—ankylosing spondylitis	0.000254	0.00126	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000254	0.00126	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—ankylosing spondylitis	0.000254	0.00126	CcSEcCtD
Norfloxacin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000253	0.00126	CcSEcCtD
Norfloxacin—Rash—Prednisolone—ankylosing spondylitis	0.000252	0.00125	CcSEcCtD
Norfloxacin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000252	0.00125	CcSEcCtD
Norfloxacin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000251	0.00125	CcSEcCtD
Norfloxacin—Fatigue—Prednisone—ankylosing spondylitis	0.000251	0.00124	CcSEcCtD
Norfloxacin—Headache—Prednisolone—ankylosing spondylitis	0.000251	0.00124	CcSEcCtD
Norfloxacin—Constipation—Prednisone—ankylosing spondylitis	0.000249	0.00123	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—ankylosing spondylitis	0.000245	0.00122	CcSEcCtD
Norfloxacin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000244	0.00121	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000243	0.00121	CcSEcCtD
Norfloxacin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000243	0.00121	CcSEcCtD
Norfloxacin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00024	0.00119	CcSEcCtD
Norfloxacin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00024	0.00119	CcSEcCtD
Norfloxacin—Asthenia—Betamethasone—ankylosing spondylitis	0.00024	0.00119	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000238	0.00118	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000238	0.00118	CcSEcCtD
Norfloxacin—Nausea—Prednisolone—ankylosing spondylitis	0.000238	0.00118	CcSEcCtD
Norfloxacin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000236	0.00117	CcSEcCtD
Norfloxacin—Pruritus—Betamethasone—ankylosing spondylitis	0.000236	0.00117	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000235	0.00117	CcSEcCtD
Norfloxacin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000234	0.00116	CcSEcCtD
Norfloxacin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000234	0.00116	CcSEcCtD
Norfloxacin—Rash—Triamcinolone—ankylosing spondylitis	0.000232	0.00115	CcSEcCtD
Norfloxacin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000232	0.00115	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—ankylosing spondylitis	0.000232	0.00115	CcSEcCtD
Norfloxacin—Rash—Methylprednisolone—ankylosing spondylitis	0.000232	0.00115	CcSEcCtD
Norfloxacin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000231	0.00115	CcSEcCtD
Norfloxacin—Urticaria—Prednisone—ankylosing spondylitis	0.000231	0.00115	CcSEcCtD
Norfloxacin—Headache—Triamcinolone—ankylosing spondylitis	0.000231	0.00114	CcSEcCtD
Norfloxacin—Headache—Methylprednisolone—ankylosing spondylitis	0.00023	0.00114	CcSEcCtD
Norfloxacin—Abdominal pain—Prednisone—ankylosing spondylitis	0.00023	0.00114	CcSEcCtD
Norfloxacin—Body temperature increased—Prednisone—ankylosing spondylitis	0.00023	0.00114	CcSEcCtD
Norfloxacin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000229	0.00113	CcSEcCtD
Norfloxacin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000229	0.00113	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000222	0.0011	CcSEcCtD
Norfloxacin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000221	0.0011	CcSEcCtD
Norfloxacin—Dizziness—Betamethasone—ankylosing spondylitis	0.000221	0.0011	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—ankylosing spondylitis	0.00022	0.00109	CcSEcCtD
Norfloxacin—Nausea—Triamcinolone—ankylosing spondylitis	0.000219	0.00109	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000218	0.00108	CcSEcCtD
Norfloxacin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000218	0.00108	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000217	0.00108	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—ankylosing spondylitis	0.000216	0.00107	CcSEcCtD
Norfloxacin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000214	0.00106	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000214	0.00106	CcSEcCtD
Norfloxacin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000212	0.00105	CcSEcCtD
Norfloxacin—Vomiting—Betamethasone—ankylosing spondylitis	0.000212	0.00105	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000211	0.00105	CcSEcCtD
Norfloxacin—Rash—Dexamethasone—ankylosing spondylitis	0.000211	0.00105	CcSEcCtD
Norfloxacin—Rash—Betamethasone—ankylosing spondylitis	0.000211	0.00105	CcSEcCtD
Norfloxacin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00021	0.00104	CcSEcCtD
Norfloxacin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00021	0.00104	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—ankylosing spondylitis	0.00021	0.00104	CcSEcCtD
Norfloxacin—Headache—Dexamethasone—ankylosing spondylitis	0.000209	0.00104	CcSEcCtD
Norfloxacin—Headache—Betamethasone—ankylosing spondylitis	0.000209	0.00104	CcSEcCtD
Norfloxacin—Asthenia—Prednisone—ankylosing spondylitis	0.000209	0.00104	CcSEcCtD
Norfloxacin—Pruritus—Prednisone—ankylosing spondylitis	0.000206	0.00102	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0002	0.000994	CcSEcCtD
Norfloxacin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000199	0.000988	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000199	0.000987	CcSEcCtD
Norfloxacin—Nausea—Dexamethasone—ankylosing spondylitis	0.000198	0.000985	CcSEcCtD
Norfloxacin—Nausea—Betamethasone—ankylosing spondylitis	0.000198	0.000985	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—ankylosing spondylitis	0.000193	0.000959	CcSEcCtD
Norfloxacin—Dizziness—Prednisone—ankylosing spondylitis	0.000192	0.000955	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000192	0.000954	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000192	0.000954	CcSEcCtD
Norfloxacin—Vomiting—Prednisone—ankylosing spondylitis	0.000185	0.000918	CcSEcCtD
Norfloxacin—Rash—Prednisone—ankylosing spondylitis	0.000183	0.00091	CcSEcCtD
Norfloxacin—Dermatitis—Prednisone—ankylosing spondylitis	0.000183	0.00091	CcSEcCtD
Norfloxacin—Headache—Prednisone—ankylosing spondylitis	0.000182	0.000905	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000179	0.000889	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—ankylosing spondylitis	0.000174	0.000866	CcSEcCtD
Norfloxacin—Nausea—Prednisone—ankylosing spondylitis	0.000173	0.000858	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—ankylosing spondylitis	0.000172	0.000854	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000166	0.000826	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—ankylosing spondylitis	0.000161	0.000798	CcSEcCtD
Norfloxacin—Vomiting—Methotrexate—ankylosing spondylitis	0.000155	0.000767	CcSEcCtD
Norfloxacin—Rash—Methotrexate—ankylosing spondylitis	0.000153	0.000761	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000153	0.00076	CcSEcCtD
Norfloxacin—Headache—Methotrexate—ankylosing spondylitis	0.000152	0.000756	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—ankylosing spondylitis	0.000144	0.000717	CcSEcCtD
